Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qiaohong Bai
Institutions:
Nanjing University of Chinese Medicine,
Nanjing Second Hospital,
Nanjing Medical University
Observed institutions:
Tongji University,
Nanjing University of Chinese Medicine,
Nanjing Second Hospital,
Nanjing Medical University
ORCID:
0000-0002-5510-315X
Observed ORCID:
0000-0002-5510-315X
OpenAlex ID:
A5067077112
Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis
2020
·
Qiaohong Bai
, Li Li
, et al.
·
Medical Science Monitor
·
19
KLF8 Promotes the Survival of Lung Adenocarcinoma During Nutrient Deprivation by Regulating the Pentose Phosphate Pathway through SIRT2
2024
·
Qiaohong Bai
, Wenfang Jin
, et al.
·
Frontiers in Bioscience-Landmark
·
7
PDF
Anlotinib as a post-third-line therapy for the treatment of advanced nonsmall cell lung cancer
2021
·
Li Li
, Wei Liu
, et al.
·
Journal of Chemotherapy
·
6
Tracheobronchial Amyloidosis with Anca-Associated Vasculitis: Rare Case Report and Review of the Literature
2024
·
Siqi Peng
, Lan Yang
, et al.
·
SSRN Electronic Journal
Retraction of “circRNA_0001679/miR-338-3p/DUSP16 axis aggravates acute lung injury”
2023
·
Jiang Zhu
, Fukuan Zhong
, et al.
·
Open Medicine
PDF
Anlotinib vs. Nanoparticle Albumin-Boundpaclitaxel in the Treatment of Third-Line and Above Extensive Stage Small Cell Lung Cancer
2021
·
Li Li
, Qiaohong Bai
, et al.
·
Research Square
PDF
Ala384Ser polymorphism of antithrombin gene and pulmonary thromboembolism
2009
·
Qiaohong Bai
, Jinming Liu
, et al.
·
Chinese Journal of Asthma
Show more works
View as search
Works count:
8
Citation count:
51
H-index:
4
I10-index:
2
Year
Topic
Type